Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 71, n° 1
pages e22-e23 (juillet 2014)
Doi : 10.1016/j.jaad.2014.01.856
JAAD Online

Collodion-like membrane in a newborn exposed to infliximab
 

Maureen Offiah, MS a, Robert T. Brodell, MD b, c, e, , Leigh R. Campbell, MD d, Julie P. Wyatt, MD b
a School of Medicine, University of Mississippi Medical Center, Jackson 
b Department of Dermatology, University of Mississippi Medical Center, Jackson 
c Department of Pathology, University of Mississippi Medical Center, Jackson 
d Department of Pediatrics-Neonatology, University of Mississippi Medical Center, Jackson 
e Department of Dermatology, University of Rochester School of Medicine and Dentistry, New York 

Correspondence to: Robert T. Brodell, MD, Department of Dermatology, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216

 Funding sources: None.
 Disclosure: Dr Brodell is on the speakers bureau for Allergan, Galderma, PharmaDerm (a division of Fougera Pharmaceuticals Inc), and Veregen; a consultant/investigator/advisory board member for Galderma Laboratories LP; and has performed multicenter clinical trials for Genentech and Janssen Biotech Inc. Ms Offiah and Drs Campbell and Wyatt have no conflicts of interest.


Top of the page

© 2014  American Academy of Dermatology, Inc.@@#104156@@